Navigation Links
MEDRAD Multi Vendor Service Launches TotalRepair(SM) on Select Ultrasound Probes
Date:3/19/2009

The first and only guaranteed ultrasound repair solution makes efficient use of shrinking healthcare budgets

WARRENDALE, Pa., March 19 /PRNewswire/ -- MEDRAD, INC., Multi Vendor Service has announced the launch of TotalRepair, the first and only guaranteed repair solution on select ultrasound probes. Enabled by 100 percent repair capabilities, TotalRepair allows healthcare facilities to spend less on costly exchanges and replacements by maximizing the use of probe repair.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

"MVS is committed to developing new repair techniques that will make equipment service budgets go farther. This has immense value to healthcare systems during grueling economic times like these," said Diane Watson, executive director of MEDRAD Multi Vendor Service. "With our ever-increasing repair capabilities and new offerings like TotalRepair, MVS can help hospitals and imaging centers save money by extending the life of their equipment."

TotalRepair not only helps healthcare facilities reduce service costs, but also mitigate overall financial exposure with a capped, guaranteed "worst case scenario" price provided up front. MVS supports its repair guarantee on eligible probes with an extended six-month warranty.*

For a complete listing of probes that are eligible for TotalRepair, please contact MVS Customer Care at 800-MEDRAD-1 x5100 or mvscustomercare@medrad.com.

*Extended six-month warranty applies only to MVS-applied service on standard probes. Transesophageal (TEE) probes are covered under a 90-day warranty.

About MEDRAD Multi Vendor Service

Multi Vendor Service, as a part of the MEDRAD Service business, provides third-party service on ultrasound transducers, parts, MRI coils and imaging product services. With the highest repair rates, superior quality and customer care, MVS provides the best value in third-party service and supports it with more than 200 field-based personnel. For more information about MEDRAD MVS, visit www.medrad.com/mvs.

About MEDRAD, INC.

MEDRAD, INC. develops, markets and services medical devices used to diagnose and treat disease. Its product offerings include fluid injection systems for radiology and cardiology, endovascular devices for the safe treatment of cardiovascular disease, magnetic resonance-compatible accessories and equipment services. MEDRAD's total 2008 revenues were over $600 million. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is a business of Bayer Medical Care. More company information is available at www.medrad.com.

Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and Bayer's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. Bayer undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.


'/>"/>
SOURCE MEDRAD, INC.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MEDRAD Molecular Imaging Earns Top Rank in Innovation
2. MEDRAD Sponsors PET Research with University of Zurich
3. MEDRAD Builds on Success of P3T Cardiac CT Injection Software
4. MEDRAD Multi Vendor Service Forms Alliance with Wetsco
5. MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
6. MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery
7. MEDRAD(R) Revenues Grow 10 Percent in 2007
8. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
9. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
10. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
11. Many Young Adults Struggle to Manage Multiple Chronic Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , ... April 24, 2017 , ... ... within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick ... Available 24 hours a day, Quick Care provides patients with the option to ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... prescription opioid overdose deaths now claim the lives of 62 Americans each day.(1) ... filings against drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on ... Blvd, for an educational and exciting 2-day program. , An attendee at a ... before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., ... case series to be presented at the 2017 National ... begins today and continues through April 22. Physicians will ... , used to assess risk for acute kidney injury ... heart failure (ADHF). Elevated levels of ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext ... of collaboration started in 2016, in which Socionext ... Brain SOINN". The companies achieved initial results in ... solution by Artificial Brain SOINN. The results will ... Big Sight, April 19-21, at booths 4505 & ...
Breaking Medicine Technology: